
Epsnorm P 2.5 Tablet
Marketer
Biologic Psychotropics India Pvt Ltd
Salt Composition
Procyclidine (2.5mg)
Overview Epsnorm P 2.5 Tablet
Parkinson's disease and medication-induced movement disorders are treated with the prescription medication Epnorm P 2.5mg tablets. These tablets enhance muscle control, alleviating stiffness for improved mobility. To minimize side effects, take Epnorm P 2.5mg tablets with food, consistently at the same time daily, maintaining a steady blood level. Follow your doctor's prescribed dosage and duration; if a dose is missed, take it immediately upon recollection. Complete the entire course, even with symptom improvement, and avoid abrupt cessation without consulting your doctor, as this may worsen symptoms. Common side effects include blurred vision, dilated pupils, lightheadedness, nausea, vomiting, upper abdominal pain, and constipation. Dizziness may occur; avoid driving or activities requiring concentration until the medicine's effects are known. Dry mouth is frequent; address this with regular mouth rinsing, good oral hygiene, and increased fluid intake. Contact lens use should be avoided due to potential dry eye. Inform your doctor of glaucoma or urinary problems. Prior to using Epnorm P 2.5mg tablets, disclose any history of heart conditions, urinary issues, liver or kidney disease, and all other medications currently being taken. Pregnant or breastfeeding individuals require physician consultation before commencing treatment.
Uses of Epsnorm P 2.5 Tablet
Movement disorders associated with Parkinson's disease and medication side effects
Major Benefits of Epsnorm P 2.5 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Epsnorm P 2.5 Tablets should be administered with a meal.
Common Side effects of Epsnorm P 2.5 Tablet:
- Dryness in mouth
- Nausea
- Vomiting
- Constipation
- Blurred vision
- Dizziness
- Lightheadedness
- Dilatation of pupil
- Epigastric pain
How to use Epsnorm P 2.5 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Epsnorm P 2.5 Tablets should be administered with food.
How Epsnorm P 2.5 Tablet works:
Myo-Ease 2.5mg tablets provide muscle relaxation by modulating excessive acetylcholine levels in the brain. This action enhances motor control and alleviates muscle rigidity. The medication benefits Parkinson's disease patients by improving movement and reducing stiffness, promoting more natural mobility. It's also indicated for treating drug-induced movement disorders characterized by restlessness, involuntary muscle movements, or spasms.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Epsnorm P 2.5 Tablet and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Epsnorm P 2.5 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks before prescribing. Seek medical advice.
Breast feedingCAUTION
The use of Epsnorm P 2.5 Tablet while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Taking Epsnorm P 2.5 Tablet might reduce awareness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Epsnorm P 2.5 Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Epsnorm P 2.5 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Epsnorm P 2.5 Tablet :
NA
Facts to Know About Epsnorm P 2.5 Tablet
| Label | Value |
|---|---|
| Chemical Category | Aralkylamine derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Class | Centrally acting anticholinergic |
